JP2017509597A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509597A5 JP2017509597A5 JP2016549420A JP2016549420A JP2017509597A5 JP 2017509597 A5 JP2017509597 A5 JP 2017509597A5 JP 2016549420 A JP2016549420 A JP 2016549420A JP 2016549420 A JP2016549420 A JP 2016549420A JP 2017509597 A5 JP2017509597 A5 JP 2017509597A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- vaca
- pylori
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 102000004169 proteins and genes Human genes 0.000 claims 10
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 239000012634 fragment Substances 0.000 claims 8
- 208000026935 allergic disease Diseases 0.000 claims 5
- 239000000284 extract Substances 0.000 claims 4
- 230000002163 immunogen Effects 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 239000013566 allergen Substances 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000004044 response Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 1
- 206010016946 Food allergy Diseases 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000024711 extrinsic asthma Diseases 0.000 claims 1
- 239000013568 food allergen Substances 0.000 claims 1
- 235000020932 food allergy Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 239000012266 salt solution Substances 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 230000003614 tolerogenic effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14153365.3A EP2902037A1 (en) | 2014-01-31 | 2014-01-31 | Tolerogenic compositions comprising and uses thereof |
| EP14153365.3 | 2014-01-31 | ||
| PCT/IB2015/050703 WO2015114575A1 (en) | 2014-01-31 | 2015-01-30 | Tolerogenic compositions comprising and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017509597A JP2017509597A (ja) | 2017-04-06 |
| JP2017509597A5 true JP2017509597A5 (OSRAM) | 2018-03-01 |
| JP6563937B2 JP6563937B2 (ja) | 2019-08-21 |
Family
ID=50028895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549420A Active JP6563937B2 (ja) | 2014-01-31 | 2015-01-30 | 寛容原性組成物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9999660B2 (OSRAM) |
| EP (2) | EP2902037A1 (OSRAM) |
| JP (1) | JP6563937B2 (OSRAM) |
| AU (1) | AU2015212357B2 (OSRAM) |
| CA (1) | CA2943149C (OSRAM) |
| DK (1) | DK3099314T3 (OSRAM) |
| ES (1) | ES2806773T3 (OSRAM) |
| WO (1) | WO2015114575A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11166986B2 (en) | 2014-01-31 | 2021-11-09 | Universitat Zurich | Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| WO2025068296A1 (en) * | 2023-09-26 | 2025-04-03 | Atopia Therapeutics Sa | Agents useful for the prevention or treatment of allergic & inflammatory disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002004017A2 (en) * | 2000-07-07 | 2002-01-17 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for preparing oral vaccines |
| US20050175629A1 (en) * | 2001-08-31 | 2005-08-11 | Giuseppe Del Giudice | Helicobacter pylori vaccination |
| JP2004189730A (ja) * | 2002-11-28 | 2004-07-08 | Japan Science & Technology Agency | 細胞死の抑制方法、細胞死抑制剤、及びその細胞死抑制剤を含む細胞死に起因する疾患の治療薬剤 |
| US11166986B2 (en) | 2014-01-31 | 2021-11-09 | Universitat Zurich | Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease |
-
2014
- 2014-01-31 EP EP14153365.3A patent/EP2902037A1/en not_active Withdrawn
-
2015
- 2015-01-30 CA CA2943149A patent/CA2943149C/en active Active
- 2015-01-30 AU AU2015212357A patent/AU2015212357B2/en active Active
- 2015-01-30 DK DK15708316.3T patent/DK3099314T3/da active
- 2015-01-30 EP EP15708316.3A patent/EP3099314B1/en active Active
- 2015-01-30 US US15/115,377 patent/US9999660B2/en active Active
- 2015-01-30 WO PCT/IB2015/050703 patent/WO2015114575A1/en not_active Ceased
- 2015-01-30 JP JP2016549420A patent/JP6563937B2/ja active Active
- 2015-01-30 ES ES15708316T patent/ES2806773T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2014502156A5 (OSRAM) | ||
| NZ701881A (en) | Vaccines for hsv-2 | |
| JP2015517489A5 (OSRAM) | ||
| JP2015521467A5 (OSRAM) | ||
| JP2015164424A5 (OSRAM) | ||
| JP2017532343A5 (OSRAM) | ||
| JP2014508734A5 (OSRAM) | ||
| RU2016152151A (ru) | Препарат, содержащий фактор viii и пептиды фактора фон виллебранда | |
| JP2018520651A (ja) | 短縮型ロタウイルスｖｐ４タンパク質およびその適用 | |
| CN103687942A (zh) | 病毒样颗粒及其制备方法 | |
| CN103467571A (zh) | 一种畜禽免疫增强剂法氏囊多肽 | |
| JP2014519817A5 (OSRAM) | ||
| EP3715359A1 (en) | Cd4 helper t cell epitope fusion peptide and vaccine therewith | |
| JP2017509597A5 (OSRAM) | ||
| HRP20241627T1 (hr) | Pneumolizinski mutanti i postupci za njihovu uporabu | |
| Schülke et al. | Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC | |
| JP2016520534A5 (OSRAM) | ||
| CN109200284B (zh) | 一种猪支原体肺炎活疫苗黏膜免疫佐剂、制备方法及其应用 | |
| JP2019534242A5 (OSRAM) | ||
| CN102337289A (zh) | 肠道病毒71型vp1蛋白的原核表达及含有该蛋白的疫苗 | |
| NZ601980A (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| JP2014502143A5 (OSRAM) | ||
| RU2018112060A (ru) | Слитый белок |